Exposure to certain toxic airborne chemicals used in industry significantly increases — by up to six times — the odds of developing amyotrophic lateral sclerosis (ALS), a study suggests. Findings underscore the importance of surveillance programs testing exposure to these airborne pollutants, especially among populations at risk. The study,…
For Albert, being active was everything. As an avid athlete all his life, he was used to challenges, but nothing could prepare him for being diagnosed with ALS. Explore how Albert drew strength from his past.
Air Force veteran Daniel knows how to succeed in tough conditions. When ALS threw him for a loop, he turned to the ALS community for the guidance to live life one day at a time. Read how Daniel found allies in fighting ALS.
Regulatory T-cells (Tregs) are a type of white blood cell that functions to suppress the body’s immune response and prevent unnecessary inflammation. Tregs are part of the immune system, and can also enter the brain and the spinal cord to reduce neuroinflammation. In amyotrophic lateral sclerosis (ALS) — a…
A new home-based neurocognitive platform from Cumulus Neurosciences is feasible to use and patient-friendly, and shows potential to identify cognitive problems and to discriminate between people with amyotrophic lateral sclerosis (ALS), those with frontotemporal dementia (FTD), and healthy individuals. That’s according to preliminary data from a first-in-class study,…
Today marks the third annual Major League Baseball (MLB) Lou Gehrig Day, set aside to honor the legacy of the famed New York Yankees first baseman whose career was shortened by amyotrophic lateral sclerosis (ALS). For the first time since the event began, all 30 MLB teams have…
On June 3, the Greater Chicago Chapter of the ALS Association will host its 2023 Chicago Walk to Defeat ALS fundraiser, with an aim of supporting patients and families living with amyotrophic lateral sclerosis (ALS). The 1.5-mile event will again take place at Cantigny Park in…
It's easy to feel isolated when dealing with a chronic disease like ALS, but help and support is available. For those who may need a little extra guidance or reassurance, we’ve compiled a variety of tips and advice from our ALS community that you may find useful.
Masitinib as an oral add-on therapy to Rilutek (riluzole) showed the greatest benefits in amyotrophic lateral sclerosis (ALS) patients with mild or moderate disease severity, an analysis of trial data showed. The findings come from the now-complete AB10015 Phase 2/3 clinical trial (NCT02588677) that excluded people…
For 30 years in the medical field, Debra saw others find the courage to move forward with tough diseases. When she heard her ALS diagnosis, she knew what to do. Learn how Debra decided to get up every day and keep going.
